Paul J Gow

Neonatal hepatic drug elimination.

P. Gow, M. S. Ching, D. Morgan, 2001, Pharmacology & toxicology.

Conjugation of para-nitrophenol by the isolated perfused neonatal sheep liver.

P. Gow, A. Shulkes, M. S. Ching, 2000, Journal of pharmaceutical sciences.

Terlipressin for Type 1 Hepatorenal Syndrome

P. Gow, A. Testro, M. Sinclair, 2020, Digestive Diseases and Sciences.

Long-term continuous terlipressin infusion in cirrhotic patients with hepatorenal syndrome or refractory ascites awaiting liver transplantation is associated with an increase in plasma sodium

A. Testro, P. Hey, B. Chapman, 2019, United European gastroenterology journal.

Hepatitis C recurrence: the Achilles heel of liver transplantation

P. Angus, P. Gow, J. Howell, 2014, Transplant infectious disease : an official journal of the Transplantation Society.

Liver transplantation for the treatment of homozygous familial hypercholesterolaemia in an era of emerging lipid‐lowering therapies

P. Gow, R. O’Brien, E. Ekinci, 2014, Internal medicine journal.

Long-term outcomes of calcineurin inhibitor withdrawal for post-liver transplant renal dysfunction.

A. Mackay, Paul J Gow, Peter W Angus, 2011, Transplantation proceedings.

Acid-Base Balance during Continuous Veno-Venous Hemofiltration: The Impact of Severe Hepatic Failure

R. Bellomo, P. Angus, P. Gow, 2006, The International journal of artificial organs.

Toll‐Like Receptor 3 and 7/8 Function Is Impaired in Hepatitis C Rapid Fibrosis Progression Post‐Liver Transplantation

N. Skinner, Paul J Gow, Dilip T Ratnam, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Low serum testosterone is associated with adverse outcome in men with cirrhosis independent of the MELD score Short title : Low testosterone in men with cirrhosis

P. Angus, P. Gow, M. Sinclair, 2016 .